Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17,257 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Xanthine oxidoreductase activity assay in tissues using stable isotope-labeled substrate and liquid chromatography high-resolution mass spectrometry.
Murase T, Nampei M, Oka M, Ashizawa N, Matsumoto K, Miyachi A, Nakamura T. Murase T, et al. Among authors: nakamura t. J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Jan 1;1008:189-197. doi: 10.1016/j.jchromb.2015.11.030. Epub 2015 Nov 25. J Chromatogr B Analyt Technol Biomed Life Sci. 2016. PMID: 26673227
Renoprotective effect of the xanthine oxidoreductase inhibitor topiroxostat on adenine-induced renal injury.
Kamijo-Ikemori A, Sugaya T, Hibi C, Nakamura T, Murase T, Oikawa T, Hoshino S, Hisamichi M, Hirata K, Kimura K, Shibagaki Y. Kamijo-Ikemori A, et al. Among authors: nakamura t. Am J Physiol Renal Physiol. 2016 Jun 1;310(11):F1366-76. doi: 10.1152/ajprenal.00517.2015. Epub 2016 Mar 30. Am J Physiol Renal Physiol. 2016. PMID: 27029427 Free article.
Association of plasma xanthine oxidoreductase activity with severity and clinical outcome in patients with chronic heart failure.
Otaki Y, Watanabe T, Kinoshita D, Yokoyama M, Takahashi T, Toshima T, Sugai T, Murase T, Nakamura T, Nishiyama S, Takahashi H, Arimoto T, Shishido T, Miyamoto T, Kubota I. Otaki Y, et al. Among authors: nakamura t. Int J Cardiol. 2017 Feb 1;228:151-157. doi: 10.1016/j.ijcard.2016.11.077. Epub 2016 Nov 9. Int J Cardiol. 2017. PMID: 27865177
Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin.
Sato K, Naganuma A, Nagashima T, Hoshino T, Uehara D, Arai Y, Horiuchi K, Yuasa K, Takayama H, Arai H, Hatanaka T, Ohyama T, Tahara H, Sohara N, Kobayashi T, Horiguchi N, Yamazaki Y, Kakizaki S, Kusano M, Yamada M, Murase T, Nakamura T. Sato K, et al. Among authors: nakamura t. Hepatol Res. 2018 Feb;48(3):E347-E353. doi: 10.1111/hepr.12971. Epub 2017 Sep 25. Hepatol Res. 2018. PMID: 28834004
17,257 results
You have reached the last available page of results. Please see the User Guide for more information.